| Tag | Content |
|---|
EnhancerAtlas ID | HS067-00104 |
Organism | Homo sapiens |
Tissue/cell | GM18522 |
Coordinate | chr1:26619720-26620690 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| Nr2f6(var.2) | MA0728.1 | chr1:26620000-26620015 | GAGGTCAGGAGTTCA | + | 6.22 |
|
| | Number of super-enhancer constituents: 6 | ID | Coordinate | Tissue/cell |
| SE_09234 | chr1:26600437-26620418 | CD14 | | SE_10276 | chr1:26609716-26620076 | CD19_Primary | | SE_11598 | chr1:26601677-26620618 | CD20 | | SE_12127 | chr1:26619203-26620020 | CD3 | | SE_18600 | chr1:26600628-26620343 | CD4p_CD25-_Il17-_PMAstim_Th | | SE_62762 | chr1:26609498-26620090 | Tonsil |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
Enhancer Sequence | CACTTGGGAT AGGAGGTAGA GTCGAGTTGA GGGCCCAGGT GTGCCTGACT CTAGAGCCTG 60
GAGAAGCATC TTTTGGGTGA CAATCTCCAT TCTTTGAAGA GAATGGGCCT GGTTTTCAGA 120
AATGGCCAGT TTTATGGACC CAAATCTGTG GGTCTATAGG AGGGGACTGT GGGAGGAATC 180
CCTCTAGATA TTAGAAGTTA AAAATAAGAC ATGGTAGGCC AGGCGTGGTG GCTCACACCT 240
GTAATCCCAG CACTTTGGGA GGCCAAGGTG GGCAGATCAC GAGGTCAGGA GTTCAAGACC 300
AGCCTGGCCA ACATGGTAAA ACCCCGTCTT TACTAAAAAT ACAAAAATTA GCTGGGTGTG 360
TTGGCACACA CTTGTAATCC TAGCTACTCA GGAGGCTGAG GCAGGAGAAT TGCTTGAACC 420
TGGGAGGCAG AGGTTGCAAT GAGCCAAATC GTGCCACTGC ACTCCAGCCT GGGTGACAGA 480
GCAAGACTCC GTCTCAAAAA AAAAAAAAAA AAAAAAAAAA AAAGACATGG TAGGGGCCCA 540
CAGAACCAGG TGGATTCCAA GGGCCATAAG CAAACCTGGA GAGGGAGGCC AAACCTGGGA 600
ATTTGGCAGC AGCTTCTAGA ACAGAAGGAT TGCCTTTTTT TAAAACGGCA ACATCTTCCA 660
GATTGGTGGC GTTTTGTAGA CTATGTGACC TGAGGCAAAT AAGGCCTTGC TACCTCTTGT 720
ATCTCTGGGT CTCTGACAGA TGAGCAAGAG AGAGCAGAGG TAGGACCGTG GAGAAGTGGG 780
CCAGCAGGTT AAGTGGTCAG TGATGGAGGC CAAGGCTGCT CCCACATTGT CTCAGGGGCA 840
AGTTGTGGGC TCTCAGGGCG TCTTGGGTCA GGGACCCGGG CACGAATGAG ATAGGCCTCT 900
GGGGAGCTGC CGGCCAACAG CAAACTGTTG GAGAATTCCT TTTGAAGAGG GCCTGGGGCA 960
GACGCCCTGC 970
|
